Infinity Pharmaceuticals, Inc. (INFI) is a drug discovery and development company that could be an interesting play for investors. That is because, not only does the stock have decent short-term ...
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and ...
Looking back to 4 days ago, Infinity Pharmaceuticals Inc (NASD: INFI) priced a 10,000,000 share secondary stock offering at $40.00 per share. Buyers in that offering made a considerable investment ...
Infinity Pharmaceuticals, Inc. INFI provided an update on a placebo-controlled phase II study, MARIO-275, evaluating the benefit of adding eganelisib to Bristol Myers Squibb’s BMY Opdivo (nivolumab) ...
Looking back to 95 days ago, Infinity Pharmaceuticals Inc (NASD: INFI) priced a 10,000,000 share secondary stock offering at $40.00 per share. Buyers in that offering made a considerable investment ...
CHICAGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- INFI USA, a pioneering AI-driven self-service software platform, today announced $12 million in Series A funding to accelerate technological innovation, ...
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results